Corcept Therapeutics (CORT) Amortizatization of Intangibles (2012 - 2025)

Corcept Therapeutics has reported Amortizatization of Intangibles for 6 years, with the latest figure at $44000.0 in Q4 2017.

• Quarterly Amortizatization of Intangibles fell 88.01% year-over-year to $44000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $500000.0 (down 74.08% YoY) and the FY2025 annual result came in at $5.1 million, down 53.35% from the prior year.
• Amortizatization of Intangibles rose to $44000.0 in Q4 2017 per CORT's latest filing, from $37000.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $5.0 million in Q3 2013 and troughed at $37000.0 in Q3 2017.
• A 5-year average of $946300.0 and a median of $717500.0 in 2015 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2013 and 2017: Amortizatization of Intangibles decreased 3.17% in 2013, then sank 91.87% in 2017.
• Over 5 years, Amortizatization of Intangibles stood at $1.1 million in 2013, then retreated by 24.86% to $804000.0 in 2014, then retreated by 18.91% to $652000.0 in 2015, then plunged by 43.71% to $367000.0 in 2016, then slumped by 88.01% to $44000.0 in 2017.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $44000.0, $37000.0, and $149000.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.